Latest News

New York, New York--(Newsfile Corp. - August 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and of

Stripe told investors on Wednesday that Jan. 1 marked the beginning of the singularity. The evidence offered was a large inflection in long-run trends, with a sharp rise in the rate of new firm creati

World Silver Survey 2026 implies data centres could consume more than 42.3 million ounces of silver annually by 2027, strengthening the long-term demand outlook.

Gold traders take some profits off the table after the strong rally.

Treasury raised its buybacks by $2 billion an operation, and the whole long end rallied. I make that 0.15% of the $1,367 billion it expects to place over two quarters.

It's been another year of record-breaking feats for ETFs. Various firms are pegging this year's inflows to cross the $2 trillion milestone, and Goldman Sachs added its stamp of approval to that foreca

Virtus Biotech ETF (BBP) is rated a buy for its focused exposure to FDA-approved biotech firms and strong recent outperformance. BBP's equal-weight, quarterly rebalancing strategy efficiently captures

Deere & Company (NYSE:DE, XETRA:DCO) reported fiscal third-quarter earnings that beat analyst estimates on both revenue and profit, sending shares up more than 7%. The agricultural and construction eq

Klaviyo (KVYO) stands out as a deeply undervalued Rule of 40 software company with robust recurring revenue and strong product momentum. KVYO is expanding its total addressable market, pushing into mi

$51.5 billion. That's Moderna's market valuation as of Thursday, marking a more than $18 billion decline from Wednesday's closing valuation of $69.6 billion.

Kaiser Aluminum Corporation delivered exceptional Q2 '26 results, driving a reassessment of normalized earnings and long-term outlook. I now estimate KALU's normalized AEPS at $10/share, up from $8, r

Following the sell-out of Phase I, Uplands Phase II introduces five new floor plans—starting from the upper $500s—in one of the South Sound's premier planned communities KEY TAKEAWAYS Grand Opening se

Although Alphabet (NASDAQ: GOOGL) lost nearly $510 billion in its market capitalization over the past three weeks, Scott Devitt, a Wall Street analyst at Rosenblatt Securities, expects this stock to r

Stryker (SYK) rebounded in Q2 with 9% organic growth, restoring confidence after a weak Q1. Both MedSurg & Neurotech and Orthopaedics segments sharply accelerated, indicating Q1 weakness was temporary

Eagle Point Income's common stock trades at a 19% discount, near its historical lows, with a 13.1% dividend yield. EIC has outperformed peers, delivering a 3-year total return on NAV of 11.64%, substa

Jack Henry & Associates (NASDAQ:JKHY) reported better-than-expected fourth-quarter financial results and issued FY27 GAAP EPS guidance above estimates, after the closing bell on Tuesday.

Key dates in the Hertz timeline disclosure events allegedly show a rapid shift from liquidity assurances and fleet discipline messaging to a dilutive financing and sharply reduced EBITDA guidance. NEW

PROCEPT analyst reaction and Wall Street securities concerns focus on allegations that investors relied on handpiece sales metrics while actual procedure demand lagged, culminating in a more than 75%

Xeris Biopharma Holdings, Inc. achieved record 2024 revenues of $203M, up 24%, with robust growth across all three commercial products. 2025 revenue guidance of $255M–$275M implies 30% growth for XERS

Sociedad Quimica y Minera TodaySQMSociedad Quimica y Minera$77.48 +2.10 (+2.79%) As of 12:34 PM Eastern52-Week Range$40.58▼$98.00Dividend Yield3.42%P/E Ratio27.19Price Target$73.58Add to WatchlistSoci